|
ATCC
primary human uterine smooth muscle cells Primary Human Uterine Smooth Muscle Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/primary human uterine smooth muscle cells/product/ATCC Average 94 stars, based on 1 article reviews
primary human uterine smooth muscle cells - by Bioz Stars,
2026-06
94/100 stars
|
Buy from Supplier |
|
PromoCell
cd31 pregnant human uterine smooth muscle cells ![]() Cd31 Pregnant Human Uterine Smooth Muscle Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd31 pregnant human uterine smooth muscle cells/product/PromoCell Average 94 stars, based on 1 article reviews
cd31 pregnant human uterine smooth muscle cells - by Bioz Stars,
2026-06
94/100 stars
|
Buy from Supplier |
|
UtSMC, Uterine Smooth Muscle Cells
|
Buy from Supplier |
|
Smooth muscle tissue is found in the tunica media layer of large and small blood vessels and in the walls of hollow organs like the bladder and the uterus. Smooth Muscle Cells (SMC) possess all
|
Buy from Supplier |
|
Cell pellet of HUtSMC from the myometrium in RNAlater® for subsequent RNA, DNA or protein analysis. Cell pellet consisting of 1 million cells dissolved in 200 µl RNAlater® for subsequent RNA, DNA or protein analysis.
|
Buy from Supplier |
Image Search Results
Journal: The Journal of Physiology
Article Title: Novel identification and modulation of the mechanosensitive Piezo1 channel in human myometrium
doi: 10.1113/jp283299
Figure Lengend Snippet: Figure 3. Piezo1-meidiated Ca2+ influx in CD31+ and CD31−human myometrial cells An intracellular calcium flux assay determined Piezo1 activity in phMEC (CD31+) and phUSMC (CD31−) cells. phMEC, phUSMC and HEK293 Piezo1KO cells were pre-treated with the Ca2+ indicator Calbryte (ex/em 493/515 nm) followed by exposure to Yoda1 (0.3 or 3 μM) ± the Piezo1 antagonist Dooku1 (10 μM) and the change in fluorescence (Cai2+) was measured. A, phMECs treated with 3 μM Yoda1 exhibited 4.09-fold increase in Ca2+ uptake (Cai2+) over 0.3 μM treated cells (P < 0.0001) which decreased by 35.74% when co-treated with Dooku1 (P = 0.0327) at 60 min. B, phUSMC experienced a 2.64-fold increase in fluorescence when challenged with 3 μM Yoda1 (P < 0.0001), with a respective decrease of 22.49% when co-treated with Dooku1 (P = 0.0326). C, Piezo1KO fluorescence did not vary significantly at any dose of Yoda1 or Yoda1 + Dooku1 relative to baseline (Kruskal–Wallis one-way ANOVA, P = 0.2622). D, left, ×10 bright field images of phMEC (top), phUSMC (middle), and Piezo1KO (bottom). Right, Calbryte-induced fluorescence after 3 μM Yoda1 stimulation. ×20 fluorescence images of phMEC (top), phUSMC (middle), and Piezo1KO (bottom). Data presented as ±SD.
Article Snippet: Cells captured by the beads were deemed CD31+ pregnant human myometrial endothelial cells (phMEC) and
Techniques: Calcium Flux Assay, Activity Assay, Fluorescence